MOUNTAIN VIEW, Calif., April 19, 2017 /PRNewswire/ -- IRIDEX Corporation (IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017. The Company's management team will host a corresponding conference call beginning at 2:30 p.m. PT / 5:30 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 92158987. A live and archived webcast of the event will be available on the "Investor Relations" section of the Company's website at: www.iridex.com. A telephone replay will also be available beginning Wednesday, May 3, 2017 through Thursday, May 4, 2017 by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers, using conference ID: 92158987.
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/iridex-to-report-first-quarter-2017-financial-results-on-may-3-2017-300441477.html